The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

President Trump has cited illegal flows of fentanyl and migrants as the main reasons for a planned 25% tariff on Mexican ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...

The San Francisco Giants pitcher on Friday spoke to students at Whitney High School in Rocklin, a campus his cousin once attended, to talk about the dangers of fentanyl, an addictive synthetic opioid.

CINCINNATI (WKRC) - A nurse is charged with mishandling dozens of opioid pills at two local nursing facilities. Amy Nicoloff, ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain.